MERILOG

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Mar 2025 filing date already counts against anyone who files later.

Record

Serial number

99084375

Mark type

Design + words

Filed

14 Mar 2025

Published for opposition

30 Dec 2025

Attorney of record

Alexandra Kochian

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the prevention and treatment of diabetes; insulin
• Class 035 — Advertising and business services: Administration of a program for enabling participants to obtain discounts on products and services; administration of a discount program for enabling participants to obtain discounts on goods and services through use of a discount membership card; promoting public awareness of medications and treatments for diabetes; Providing business information in the field of patient relationship management services for the purpose of assisting prospective patients regarding the treatment of disease via a web site; Providing business information in the field of business administration of patient reimbursement programs, namely, medical treatment payment plan options for patients undergoing treatment of disease
• Class 041 — Education and entertainment services: Providing training in the field of diabetes and diabetes care provided by means of injecting insulin; publication of printed and online articles and scientific journals in the field of health care and medicine; Educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of healthcare and medicine for health care providers, care givers, health care insurers, payers in the healthcare field, patients with diabetes and related diseases and disorders, and patients with autoimmune diseases; Entertainment services, namely, providing podcasts in the field of healthcare and medicine; Educational services, namely, conducting conferences, training, seminars, congresses, presentations, and workshops in the field of healthcare and medicine and distribution of educational materials in connection therewith, all the foregoing distributed via various platforms across multiple forms of transmission media, namely, via the Internet and social network platforms
• Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of diabetes; providing medical information; Medical services; medical services in the field of diabetes, autoimmune diseases and disorders, and related diseases and disorders, namely, providing medical and psychological support for healthcare professionals, patients with diabetes and related diseases and disorders, and patients with autoimmune diseases and disorders; providing medical information in the field of prevention and treatment of diabetes, autoimmune diseases and disorders, and diseases and disorders related to diabetes; providing medical information in the field of diabetes, treatment of the disease, burden of the disease, and pathophysiology of the autoimmune nature of the disease via a website; providing medical information in the field of diabetes, autoimmune diseases, and related diseases and disorders, and on the prevention and early diagnosis of asymptomatic Type 1 diabetes, to health care providers; providing medical information in the field of diabetes and autoimmune diseases to patients, health care professionals, and caregivers, all of the foregoing distributed via various platforms across multiple forms of transmission media, namely, via electronic media, the Internet, and social network platform; providing educational information to caregivers and patients in the field of personal support services for families of patients with life threatening disorders, namely, information concerning companionship support, help with medical forms, patient treatment management, all of the aforesaid provided by means of website or telephone, non-downloadable webinars, and printed materials distributed in connection therewith; Providing educational information about healthcare

Owner

• Sanofi, Paris, FR
• Sanofi, Paris, FR

Prosecution history

• 24 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 30 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 30 Dec 2025 — PUBLISHED FOR OPPOSITION
• 24 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 01 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 31 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 31 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 31 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 22 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 22 Aug 2025 — NON-FINAL ACTION E-MAILED
• 22 Aug 2025 — NON-FINAL ACTION WRITTEN
• 14 Aug 2025 — ASSIGNED TO EXAMINER
• 03 Aug 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
• 03 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 30 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS